Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-05-20
2008-05-20
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S447000, C514S448000, C549S063000, C549S064000, C549S069000, C549S072000
Reexamination Certificate
active
07375131
ABSTRACT:
The present invention provides novel compounds and methods for using them to treat diseases with aminothiophene inhibitors of IKK-β phosphorylation of IκB. In so doing these aminothiophene inhibitors block pathological activation of transcription factor NF-κB in which diseases excessive activation of NF-κB is implicated.
REFERENCES:
patent: 3963750 (1976-06-01), Goudie
patent: 5378703 (1995-01-01), Dean et al.
patent: 6875790 (2005-04-01), Bertenshaw et al.
patent: 6881735 (2005-04-01), Schindler et al.
patent: 6881741 (2005-04-01), Chan Chun Kong et al.
patent: 7019027 (2006-03-01), Linden et al.
patent: 7084170 (2006-08-01), Grossman et al.
patent: 7084171 (2006-08-01), Grainger et al.
patent: 7098240 (2006-08-01), Griffiths et al.
patent: 7166639 (2007-01-01), Wan et al.
patent: 7179836 (2007-02-01), Adams et al.
patent: 7196114 (2007-03-01), Schoenafinger et al.
patent: 538231 (1993-04-01), None
patent: 200260658 (2002-02-01), None
patent: WO 99/46244 (1999-03-01), None
patent: WO 01/98290 (2001-06-01), None
patent: WO 01/58890 (2001-08-01), None
patent: WO 02/30353 (2002-04-01), None
patent: WO 03/010158 (2002-07-01), None
Bonafoux, Dominique et al, CA 143: 460021, 2005.
Bonafoux, Dominique et al, CA143: 153240, 2005.
Griffiths et al., “Preparation of Ureido-Carboxamido Thiophenes as Inhibitors of IKK2 Kinase”. Database HCAPLUS on STN, AN 2003:97415. CA 138: 153430.
Database Registry—Chemical Abstracts Service, Columbus, OH, Feb. 25, 2003. Database Accession No. RN 494772-50-8 (Abstract) & Database Caplus Chemical Abstracts Service, Columbus, OH. XP002398375.
Callahan James F.
Li Yue Hu
Madden Laura K.
McCarthy Mary
Saeed Kamal A.
Sauermelch Loretta
SmithKlineBeecham Corp.
LandOfFree
NF-κB inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with NF-κB inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and NF-κB inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2762206